---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-015647"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2025-02-20T23:59:59+00:00"
generated_at: "2026-05-26T09:13:47.074610+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA abandons plan to acquire Poolbeg Pharma; issues Rule 2.8 no-offer statement

## Summary
- HOOKIPA board decides not to proceed with all-share acquisition of Poolbeg Pharma announced on Jan 2, 2025.
- Announcement made under UK Takeover Code Rule 2.8; HOOKIPA reserves right to reverse under certain conditions.
- Discussions for combination have ceased; no firm offer was made.
- Financial adviser Moelis & Company advised HOOKIPA on the potential deal.

## SEC filing metadata
- accession: 0001104659-25-015647
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2025-02-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465925015647/0001104659-25-015647-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465925015647/tm257203d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-015647
- JSON: https://secwatch.observer/filing/0001104659-25-015647.json
- Plain text: https://secwatch.observer/filing/0001104659-25-015647.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.